Citation 189806

PFITSCHER,A: REITER,E: JUNGBAUER,A:. (2008). RECEPTOR BINDING AND TRANSACTIVATION ACTIVITES OF RED CLOVER ISOFLAVONES AND THEIR METABOLITES. 112()

Citation Details

Title	RECEPTOR BINDING AND TRANSACTIVATION ACTIVITES OF RED CLOVER ISOFLAVONES AND THEIR METABOLITES
Authors	PFITSCHER,A: REITER,E: JUNGBAUER,A:
Year	2008
Volume	112
Issue

Summary

Year: 2008

Journal: Unknown

Organisms and Their Experiments (2)

Trifolium pratense (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
3	Not specified	PRESENT IN (REVIEW)	BIOCHANIN AGENISTEINFORMONONETINDAIDZEIN	None
4	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A	ACTIVE
5	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A	ACTIVE
6	ANDROGENIC RECEPTOR BINDING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A	ACTIVE
7	ESTROGEN RECEPTOR TRANSCRIPTION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A	ACTIVE
8	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	ACTIVE
9	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	ACTIVE
11	ESTROGEN RECEPTOR TRANSCRIPTION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	ACTIVE
12	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
13	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
14	ANDROGENIC RECEPTOR BINDING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	WEAK ACTIVITY
15	ESTROGEN RECEPTOR TRANSCRIPTION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
16	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN	ACTIVE
17	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN	ACTIVE
18	ANDROGENIC RECEPTOR BINDING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN	WEAK ACTIVITY
19	ESTROGEN RECEPTOR TRANSCRIPTION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN	ACTIVE

(FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
2	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A, DIHYDRO:	WEAK ACTIVITY
3	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A, DIHYDRO:	WEAK ACTIVITY
5	ESTROGEN RECEPTOR TRANSCRIPTION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A, DIHYDRO:	ACTIVE
9	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN, DIHYDRO:	WEAK ACTIVITY
10	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN, DIHYDRO:	WEAK ACTIVITY
11	ANDROGENIC RECEPTOR BINDING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN, DIHYDRO:	WEAK ACTIVITY
12	ESTROGEN RECEPTOR TRANSCRIPTION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN, DIHYDRO:	ACTIVE
13	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN, DIHYDRO:	ACTIVE
14	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN, DIHYDRO:	ACTIVE
15	ANDROGENIC RECEPTOR BINDING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN, DIHYDRO:	WEAK ACTIVITY
16	ESTROGEN RECEPTOR TRANSCRIPTION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN, DIHYDRO:	WEAK ACTIVITY
17	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN, DIHYDRO:	ACTIVE
18	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN, DIHYDRO:	ACTIVE
19	ANDROGENIC RECEPTOR BINDING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN, DIHYDRO:	WEAK ACTIVITY
20	ESTROGEN RECEPTOR TRANSCRIPTION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN, DIHYDRO:	WEAK ACTIVITY
21	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	EQUOL	ACTIVE
22	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	EQUOL	ACTIVE
23	ANDROGENIC RECEPTOR BINDING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EQUOL	WEAK ACTIVITY
24	ESTROGEN RECEPTOR TRANSCRIPTION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	EQUOL	ACTIVE
25	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ANGOLENSIN	ACTIVE
26	ESTROGEN RECEPTOR BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ANGOLENSIN	ACTIVE
27	ANDROGENIC RECEPTOR BINDING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ANGOLENSIN	WEAK ACTIVITY
28	ESTROGEN RECEPTOR TRANSCRIPTION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANGOLENSIN	ACTIVE

Citation 189806

Citation Details

Summary

Organisms and Their Experiments (2)

Trifolium pratense (FABACEAE)

(FABACEAE)

Show SPARQL Queries (1)

Query 1